Danny Dragovic

Danny Dragovic is the Director of Business Development for Asia-Pacific at CSL, where they leverage over 18 years of experience in the pharmaceutical industry. They have held senior positions at major global companies, including Fresenius Kabi and Hospira, focusing on strategic marketing and commercial portfolio strategy. Danny earned a Bachelor of Business in Marketing from La Trobe University and a Bachelor of Applied Science from RMIT University, further enhancing their expertise with studies in Strategic Alliances and M&A at The Wharton School. They are known for their ability to manage P&Ls across diverse business segments while fostering key customer and partner relationships.